2023
DOI: 10.5603/ahp.a2023.0034
|View full text |Cite
|
Sign up to set email alerts
|

Revolution in management of CMV infection after hematopoietic cell transplantation

Abstract: The work described in this article has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans; EU Directive 2010/63/EU for animal experiments; Uniform requirements for manuscripts submitted to biomedical journals.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Significant progress has been achieved in the management of cytomegalovirus (CMV) [6] with the introduction of letermovir in prophylaxis in patients after allogeneic hematopoietic cell transplantation (allo-HCT). Hopefully, this will also be licensed for children.…”
Section: Viral Complicationsmentioning
confidence: 99%
“…Significant progress has been achieved in the management of cytomegalovirus (CMV) [6] with the introduction of letermovir in prophylaxis in patients after allogeneic hematopoietic cell transplantation (allo-HCT). Hopefully, this will also be licensed for children.…”
Section: Viral Complicationsmentioning
confidence: 99%